Skip to content

Diabetes Disparities: Texting to Extend Treatment (DD-TXT)

Diabetes Disparities: Texting to Extend Treatment (DD-TXT)

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04227379
Acronym
DD-TXT
Enrollment
366
Registered
2020-01-13
Start date
2023-01-30
Completion date
2025-04-30
Last updated
2026-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Keywords

text messaging, Health Equity, Health Care Quality, Access, and Evaluation, self-management

Brief summary

One way to help Veterans improve their diabetes control is through the use of technology to help provide information, motivation, and reminders necessary to support diabetes self-management. The study will seek input from diverse groups of Veterans living with diabetes to help develop a new customizable, interactive texting intervention that allows Veterans to choose what kinds of diabetes self-management support they need, and when. This diabetes support will be provided to Veterans through "Annie for Veterans", a VA texting system for self-management support. Patients will be randomized to receive a once-daily standard diabetes self-management texting intervention called DSMS based on standard diabetes self-management education content or a customizable, patient-centered diabetes self-management support intervention with additional features called DSMS Plus (DSMS+) in order to test the comparative effectiveness of these two texting interventions.

Detailed description

Type 2 Diabetes is a common, complex health condition which can result in many serious and costly health complications if not treated and controlled properly. One in four Veterans are diagnosed with Type 2 Diabetes. Vulnerable Veterans, such as minority, low-income, or rural Veterans, and Veterans with comorbid mental health diagnoses, are disproportionately affected and are less likely to have their diabetes under control. The goal of this study, using a randomized comparative effectiveness design, was to test the comparative effectiveness of an interactive, customizable diabetes self-management support texting protocol (DSMS+), versus a standardized education-only intervention (DSMS) in a sample of Veterans with uncontrolled diabetes. The team will invited Veterans age 18 years and above who were actively receiving care at the study sites (as determined by upcoming scheduled appointment) who had uncontrolled glucose (HbA1c \>= 8.0% for at least 50% of the most recent 6 months). Participants who met these conditions and enrolled in the study were randomized to one of two study arms: DSMS or DSMS+. Both arms received text-based diabetes self-management support for 6 months. The primary outcome was HbA1c percent time in control. Secondary outcomes include self-reported adherence to diabetes self-care recommendations (SCI-R), diabetes self-efficacy, diabetes distress, LDL, and blood pressure control. The team hypothesized that the customizable texting intervention (DSMS+) would result in better proximal health outcomes and diabetes self-management behaviors vs a standardized, education-only protocol (DSMS). Please note that we previously referred to DSMS as DSE (diabetes standardized education) and DSMS+ as DD-TXT (Diabetes Disparities: Texting to Extend Treatment) after the trial name. We updated the names to better clarify that both are diabetes self-management support texting interventions, with DSMS+ having additional, customizable and interactive content that patients can choose from.

Interventions

BEHAVIORALIntervention 1- DSMS+

Participants in this group were signed up for an interactive, patient-centered, and customizable diabetes self-management support texting intervention (DSMS+). This arm received the same daily educational content as the DSMS arm augmented by the following: regular two-way check-in messages about diabetes self-management behaviors, an invitation to receive messages written by other Veterans living with diabetes on demand, and a menu of optional and customizable modules (e.g., medication reminders, blood sugar and blood pressure monitoring,: physical activity reminders, weight management, and goal setting) from which participants could select messaging th

BEHAVIORALComparison - DSMS

Participants in the comparison condition were signed up for a one-way education-only protocol called Diabetes Self-Management Support (DSMS), comprised of 6 months of once daily one-way text messages covering standard diabetes self-management education content. Starting with the VA educational workbook entitled "Self-Care Skills for the Person with Diabetes", created in alignment with VA/DoD diabetes guidelines, we enhanced the educational content by incorporating Veteran input through a co-design process with Veterans living with diabetes and expert clinician review. DSMS messages could not be customized. There was no interactive content for the DSMS arm other than a once monthly message asking whether the messages had been helpful.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Masking description

All participants received a diabetes self-management support texting intervention but they were not explicitly told whether their intervention was part of the experimental (DSMS+) or comparison (DSMS) arm.

Intervention model description

Patients who consented to participate were asked to complete the baseline survey instruments. Participants were then randomized to a study arm, using a separate randomization table per site. Since women are underrepresented among VHA patients, the study staff recruited women first to oversample them, with the goal of 10-20% women at each site. The goal was to recruit 400 participants (200 per site). Participants in both arms were asked to complete a follow-up survey and interview after completing the 6-month texting intervention they were assigned.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Veterans * Active VHA patients with type 2 diabetes * Had at least 4 VA outpatient encounters in the previous year * Have a future appointment scheduled, and not be hospitalized or institutionalized or have participated in texting intervention development * Have HbA1c lab data (2+ values) in the 12 months prior to RCT recruitment. * Have inadequate glycemic control for at least 50% of the 6 months before invitation to participate

Exclusion criteria

* Non-Veterans * Not having access to their own or a cohabiting family member's cell phone or smartphone for participation * Not willing and able to text * A visual impairment that would prevent them from reading or replying to text messages * Cognitively incapable of consent to participate (Failure of Short Blessed Test)

Design outcomes

Primary

MeasureTime frameDescription
Change in HbA1c Percent Time in Controlpre-enrollment, 6 month follow upThe investigators examined the changes in HbA1c percent time in control. The cutoff for being in control was a HbA1c of 8.0 percent. Using HbA1c measures pulled from the electronic medical record data, we estimated the percentage of time HbA1c\<8.0% in the 6 month window prior to enrollment and during the 6 month trial. We then calculated the change in HbA1c percent time in control for each participant.
Change in HbA1cpre-enrollment, 6 month follow-upWe examined the changes in HbA1c. These data were calculated using HbA1c measures pulled from the electronic medical record data prior to and after trial enrollment. The pre-enrollment HbA1c was measured by the closest HbA1c value before enrollment. The 6-month follow-up HbA1c was measured by the closest A1c to day 180 (6-months post-enrollment) available within the window of 91-271 days post-enrollment. The change was calculated by subtracting the pre-enrollment value from the 6-month value.

Secondary

MeasureTime frameDescription
Change in LDLpre-enrollment, 6 month follow upWe examined the changes in LDL. These data were calculated using LDL measures pulled from the electronic medical record data prior to and after trial enrollment. The pre-enrollment HbA1c was measured by the mean LDL value in the 6 months prior to enrollment. The 6-month follow-up LDL was measured by the mean of any LDL values available within the window of 91-271 days post-enrollment. The change was calculated by subtracting the pre-enrollment value from the 6-month value.
Change in Systolic Blood Pressurepre-enrollment, 6 month follow upWe examined the changes in systolic blood pressure (SBP). These data were calculated using blood pressure readings pulled from the electronic medical record data prior to and after trial enrollment. The pre-enrollment SBP was measured by the mean SBP in the year (365 days) prior to enrollment. The 6-month follow-up SBP was measured by the mean SBP taken within the window of 91-271 days post-enrollment. The change was calculated by subtracting the pre-enrollment value from the 6-month value.
Change in Diastolic Blood Pressurepre-enrollment, 6 monthsWe examined the changes in diastolic blood pressure (DBP). These data were calculated using blood pressure readings pulled from the electronic medical record data prior to and after trial enrollment. The pre-enrollment DBP was measured by the mean DBP in the year (365 days) prior to enrollment. The 6-month follow-up DBP was measured by the mean DBP taken within the window of 91-271 days post-enrollment. The change was calculated by subtracting the pre-enrollment value from the 6-month value.
Change in Self-reported Adherence to Diabetes Self-care Recommendations (SCI-R)Baseline, 6 monthsSecondary outcomes included self-reported adherence to diabetes self-care recommendations (SCI-R). We administered the SCI-R to participants via an online survey at enrollment and again at the 6-month follow-up. The score was calculated by averaging the 12 items relevant to type 2 diabetes, each item scored 1(Never) to 5(Always), and converting to a 0-100 scale. A higher score was better. We calculated the difference between the follow-up score and baseline.
Change in Self-reported Diabetes Self-efficacy Scale (DSES)Baseline, 6 monthsWe measured diabetes self-efficacy using the Diabetes Self-Efficacy Scale (DSES). We administered the DSES to participants via an online survey at enrollment and again at 6-month follow-up. The score was calculated by the average of 8 items, each item 1(Not at all Confident) to 10(Totally Confident), with a theoretical scale of 1 to 10, and a higher score was better. We calculated the difference between the follow-up score and baseline.
Change in Self-reported Diabetes Distress Scale (DDS17)Baseline, 6 monthsSecondary outcomes included self-reported diabetes distress measured by the Diabetes Distress Scale (DDS17). We administered the DDS17 to participants via an online survey at enrollment and again at the 6-month follow-up. The score was calculated by the average of 17 items, each item 1(Not a problem) to 6(Very Serious Problem), with a theoretical score range of 1 to 6, and a lower score was better. We calculated the change between the follow-up score and baseline.
Change in Self-reported DDS17 Emotional Burden SubscaleBaseline, 6 monthsThe DDS17 Emotional Burden Subscale is a subscale of the Diabetes Distress Scale (DDS17). We administered the DDS17 to participants via an online survey at enrollment and again at the 6-month follow-up. The score was calculated by the average of 5 items, each item 1(Not a problem) to 6(Very Serious Problem), with a theoretical score range of 1 to 6, and a lower score was better. We calculated the difference between the follow-up score and baseline.
Change in Self-reported DDS17 Physician-related Distress SubscaleBaseline, 6 monthsThe DDS17 Physician-Related Distress Subscale is a subscale of the Diabetes Distress Scale (DDS17). We administered the DDS17 to participants via an online survey at enrollment and again at the 6-month follow-up. The score was calculated by the average of 4 items, each item 1(Not a problem) to 6(Very Serious Problem), with a theoretical score range of 1 to 6, and a lower score was better. We calculated the difference between the follow-up score and baseline.
Change in Self-reported DDS17 Regimen-Related Distress SubscaleBaseline, 6 monthsThe DDS17 Regimen-Related Distress Subscale is a subscale of the Diabetes Distress Scale (DDS17). We administered the DDS17 to participants via an online survey at enrollment and again at the 6-month follow-up. The score was calculated by the average of 5 items, each item 1(Not a problem) to 6(Very Serious Problem), with a theoretical score range of 1 to 6, and a lower score was better. We calculated the difference between the follow-up score and baseline.
Change in Self-reported DDS17 Interpersonal Distress SubscaleBaseline, 6 monthsThe DDS17 Interpersonal Distress Subscale is a subscale of the Diabetes Distress Scale (DDS17). We administered the DDS17 to participants via an online survey at enrollment and again at the 6-month follow-up. The score was calculated by the average of 3 items, each item 1(Not a problem) to 6(Very Serious Problem), with a theoretical score range of 1 to 6, and a lower score was better. We calculated the difference between the follow-up score and baseline.
Change in Self-reported Adherence to Refills and Medications Scale for Diabetes (ARMS-D)Baseline, 6 monthsWe measured self-reported adherence to diabetes medications using the ARMS-D. We administered the ARMS-D to participants via an online survey at enrollment and again at 6-month follow-up. The score was calculated by the sum of 11 items, each item 1(None of the time) to 4(All of the time), with a theoretical score range of 11 to 44, and a lower score was better. We calculated the difference between the follow-up score and baseline.
Change in Self-reported Physical Health Summary ScoreBaseline, 6 monthsSecondary outcomes included self-reported physical health. This was collected from the patient via a questionnaire conducted over the phone. The score was calculated through an algorithm that transforms the 12 items from the Veterans RAND 12 Item Health Survey (VR-12) into a theoretical scale of 0-100 points, and a higher score was better. We calculated the difference between the follow-up score and baseline.
Change in Self-reported Mental Health Summary ScoreBaseline, 6 monthsSecondary outcomes included self-reported mental health. This was collected from the patient via a questionnaire conducted over the phone. The score was calculated through an algorithm that transforms the 12 items from the Veterans RAND 12 Item Health Survey into a theoretical scale of 0-100 points, and a higher score was better. We calculated the difference between the follow-up score and baseline.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORStephanie L Shimada, PhD

VA Bedford HealthCare System, Bedford, MA

Baseline characteristics

Characteristic
Age, Customized
18 to 44
16 Participants
Age, Customized
45 to 64
93 Participants
Age, Customized
65+
161 Participants
Annual Income
$100,000 to $149,999
15 Participants
Annual Income
$10,000 to $19,999
15 Participants
Annual Income
$150,000 or more
4 Participants
Annual Income
$20,000 to $29,999
12 Participants
Annual Income
$30,000 to $39,999
22 Participants
Annual Income
$40,000 to $49,999
29 Participants
Annual Income
$50,000 to $59,999
21 Participants
Annual Income
$60,000 to $69,999
30 Participants
Annual Income
$70,000 to $79,999
8 Participants
Annual Income
$80,000 to $89,999
8 Participants
Annual Income
$90,000 to $99,999
16 Participants
Annual Income
Less than $10,000
15 Participants
Annual Income
Prefer Not to Answer
1 Participants
Education
Associate's degree
16 Participants
Education
Bachelor's degree
38 Participants
Education
Doctoral Degree
5 Participants
Education
High School Graduate
29 Participants
Education
Master's degree
16 Participants
Education
Prefer Not to Answer
1 Participants
Education
Some college or vocational school
63 Participants
Education
Some High School
12 Participants
Employment Status
Disabled/Unable to work
73 Participants
Employment Status
Employed
58 Participants
Employment Status
Prefer Not to Answer
2 Participants
Employment Status
Retired
74 Participants
Employment Status
Unemployed
13 Participants
Housing
Home of a family member or friend
19 Participants
Housing
Missing
5 Participants
Housing
Other
23 Participants
Housing
Own home/apt
150 Participants
Housing
Prefer Not to Answer
3 Participants
Race/Ethnicity, Customized
American Indian/Alaska Native
3 Participants
Race/Ethnicity, Customized
Asian
1 Participants
Race/Ethnicity, Customized
Black
89 Participants
Race/Ethnicity, Customized
Hispanic
17 Participants
Race/Ethnicity, Customized
Multi-racial
5 Participants
Race/Ethnicity, Customized
Native Hawaiian/Pacific Islander
1 Participants
Race/Ethnicity, Customized
Non-Hispanic
172 Participants
Race/Ethnicity, Customized
Other
9 Participants
Race/Ethnicity, Customized
Prefer Not to Answer
1 Participants
Race/Ethnicity, Customized
White
72 Participants
Relationship Status
In a relationship
189 Participants
Relationship Status
Missing
1 Participants
Relationship Status
Not in a relationship
83 Participants
Relationship Status
Prefer Not to Answer
3 Participants
Rurality
Rural
35 Participants
Rurality
Urban
154 Participants
Sex/Gender, Customized
Female
117 Participants
Sex/Gender, Customized
Male
248 Participants
Sex/Gender, Customized
Other
0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
1 / 1861 / 180
other
Total, other adverse events
0 / 1860 / 180
serious
Total, serious adverse events
1 / 1862 / 180

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 27, 2026